HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sylwia Tarka Selected Research

Nucleoproteins

1/2021Neuropathological analysis of the brains of fifty-two patients with COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sylwia Tarka Research Topics

Disease

4Traumatic Brain Injuries (Traumatic Brain Injury)
08/2019 - 11/2017
2Wounds and Injuries (Trauma)
06/2020 - 01/2019
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2021
1Leukocytosis (Pleocytosis)
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Disease Progression
01/2020
1Craniocerebral Trauma (Head Injury)
01/2018
1Hemorrhage
01/2018
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2014
1Gliosis
01/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2014
1Immune System Diseases (Immune Disorders)
01/2011

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
08/2019 - 11/2017
3tau Proteins (tau Protein)IBA
01/2018 - 01/2014
2Ethanol (Ethyl Alcohol)IBA
06/2020 - 01/2019
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
08/2019 - 01/2014
1AntibodiesIBA
01/2021
1NucleoproteinsIBA
01/2021
1Valproic Acid (Depakote)FDA LinkGeneric
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1DNA Polymerase gammaIBA
01/2020
1Dyneins (Dynein)IBA
01/2019
1KinesinsIBA
01/2019
1Dynactin ComplexIBA
01/2019
1Histones (Histone)IBA
01/2018
1Glial Fibrillary Acidic ProteinIBA
01/2018
1Peptides (Polypeptides)IBA
01/2018
1Myelin Basic ProteinIBA
01/2018
1Protein Isoforms (Isoforms)IBA
01/2014
1Amyloid (Amyloid Fibrils)IBA
01/2011